Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | DGKA | P23743 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1619852 | 0.83 | LMNA (0.40) | USP2LMNAALDH1A1CYP1A2KDM4E | |
| SCHEMBL4623780 | 0.82 | USP2 (0.35) | USP2LMNATSHRALDH1A1TDP1 | |
| SCHEMBL9668195 | 0.80 | ALDH1A1 (0.31) | TSHRALDH1A1MAPK1 | |
| SCHEMBL17237504 | 0.80 | USP2 (0.34) | USP2LMNATSHRALDH1A1TDP1 | |
| SCHEMBL1357902 | 0.78 | LMNA (0.44) | USP2LMNATSHRALDH1A1CYP1A2 | |
| SCHEMBL888322 | 0.76 | TSHR (0.43) | USP2LMNATSHRALDH1A1TDP1 | |
| SCHEMBL1487123 | 0.75 | — | — | |
| SCHEMBL5027030 | 0.75 | — | — | |
| SCHEMBL7624990 | 0.75 | — | — | |
| SCHEMBL764019 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2320863-B1 | CLEANSING COMPOSITION | KAO GERMANY GMBH (DE) | 2018-05-16 | — | — | EP | claimed |
| EP-2320855-B1 | CONDITIONING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2017-12-27 | — | — | EP | claimed |
| EP-2320862-B1 | CLEANSING COMPOSITION | KAO GERMANY GMBH (DE) | 2016-04-27 | — | — | EP | claimed |
| EP-2320856-B1 | CONDITIONING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2015-11-11 | — | — | EP | claimed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
| US-20210227863-A1 | HIGH INTENSITY SWEETENERS | SENOMYX, INC. | 2021-07-29 | — | — | US | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| EP-3356356-B1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED (US) | 2021-05-26 | — | — | EP | disclosed |
| US-20200283650-A1 | INK COMPOSITION | SEIKO EPSON CORPORATION (JP) | 2020-09-10 | — | — | US | disclosed |
| WO-2017075257-A2 | HIGH INTENSITY SWEETENERS | SENOMYX, INC. (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED | 2017-04-06 | — | — | US | disclosed |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | SENOMYX INC (US) | 2017-03-30 | — | — | US | disclosed |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | SENOMYX INC (US) | 2016-12-29 | — | — | US | disclosed |
| US-9029293-B2 | Tobacco axillary bud inhibitor and tobacco axillary bud-inhibiting method | SDS BIOTECH K.K. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-8865624-B2 | Inhibitor for tobacco axillary bud growth and method for inhibiting tobacco axillary bud growth | SDS BIOTECH K.K. (JP) | 2014-10-21 | — | — | US | disclosed |
| US-20140121112-A1 | TOBACCO AXILLARY BUD INHIBITOR AND TOBACCO AXILLARY BUD-INHIBITING METHOD | SDS BIOTECH K.K. (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20130157857-A1 | INHIBITOR FOR TOBACCO AXILLARY BUD GROWTH AND METHOD FOR INHIBITING TOBACCO AXILLARY BUD GROWTH | SDS BIOTECH K.K. (JP) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | USP2 4693/4885LMNA 4834/4885TSHR 3246/4885 |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | TAS2R5, TAS1R1, TAS2R1 | USP2 3953/4885LMNA 4440/4885TSHR 2120/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | USP2 4693/4885LMNA 4834/4885TSHR 3246/4885 |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | TRPA1, PDE6G, PDE6D | USP2 3149/4885LMNA 4541/4885TSHR 2063/4885 |
| US-20210227863-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | USP2 4693/4885LMNA 4834/4885TSHR 3246/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | USP2 4693/4885LMNA 4834/4885TSHR 3246/4885 |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | TRPM8, TRPM6, TRPM4 | USP2 4285/4885LMNA 4164/4885TSHR 2031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.